FGFR3-IN-10

Overview

FGFR3-IN-10 is a FGFR3 inhibitor with superior selectivity for FGFR3 over FGFR1 .FGFR3-IN-10 can be used for the research of cancer , systemic sclerosis, fibrosis, pulmonary fibrosis, achondroplasia, thanatophoric dysplasia, severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN), Muenke syndrome.

Application

Products | Products > Disease Areas > Pulmonary Disease | Products > Disease Areas > Multiple Sclerosis | Products > Disease Areas > Lung Fibrosis | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Respiratory Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Autoimmune Disease | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Neurological Disease | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > FGFR

Product Information

• Catalog No.: HY-122833
• CAS No.: 2833703-74-3
• Molecular Formula: C23H22ClFN8O2
• Molecular Weight: 496.92
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source